Skip to main content

May 7, 2020: Oncology Pharmacy: COVID-19 Impact on Cancer Care and Road to Recovery

Michael Ganio, PharmD
Senior Director
Pharmacy Practice and Quality
American Society of Hospital Pharmacists
Chris Marcum, PharmD
Enterprise Pharmacy
Cancer Treatment Centers of America
Ali McBride, PharmD, MBA
Clinical Coordinator
University of Arizona Cancer Center
Stacey McCullough, PharmD
Tennessee Oncology, LLC
Bhavesh Shah, RPh, BCOP
Director of Specialty and Hematology/Oncology Pharmacy, Boston Medical Center
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
In this discussion, moderated by Niesha Griffith, RPh, MS, FASHP, CPO (interim), a panel of oncology pharmacists discuss the impact of the COVID-19 pandemic on their practices, the increase in the use of new technologies as a result of recent events, and how the influx of patients expected in the coming weeks will affect their daily operations.

Related Items